Dhiraj Acharya

Dhiraj Acharya

Auto-generated profile, based on publicly available information

Dhiraj Acharya

Florida Research and Innovation Center, Cleveland Clinic

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
25 November 2022 in Science Immunology
Verified
Journal Article
Closed access
LNLeslie Naesens
Leslie Naesens
SMSantoshi Muppala
Santoshi Muppala
DADhiraj Acharya
Dhiraj Acharya
JNJosephine Nemegeer
Josephine Nemegeer
DBDelfien Bogaert
Delfien Bogaert
FHFilomeen Haerynck
Filomeen Haerynck
Herpes simplex virus 1 (HSV-1) infects several billion people worldwide and can cause life-threatening herpes simplex encephalitis (HSE) in some patients. Monogenic defects in components of the type I interferon system have been identified in patients with HSE, emphasizing the role of inborn errors of immunity underlying HSE pathogenesis. Here, we identify compound heterozygous loss-of-function mutations in the gene GTF3A encoding for transcription factor IIIA (TFIIIA), a component of the RNA polymerase III complex, in a patient with common variable immunodeficiency and HSE. Patient fibroblasts and GTF3A gene–edited cells displayed impaired HSV-1–induced innate immune responses and enhanced HSV-1 replication. Chromatin immunoprecipitation sequencing analysis identified the 5 S ribosomal RNA pseudogene 141 ( RNA5SP141 ), an endogenous ligand of the RNA sensor RIG-I, as a transcriptional target of TFIIIA. GTF3A mutant cells exhibited diminished RNA5SP141 expression and abrogated RIG-I activation upon HSV-1 infection. Our work unveils a crucial role for TFIIIA in transcriptional regulation of a cellular RIG-I agonist and shows that GTF3A genetic defects lead to impaired cell-intrinsic anti–HSV-1 responses and can predispose to HSE.

20 July 2023 in Cell Host & Microbe
Verified
Journal Article
Closed access
TSTaryn Serman
Taryn Serman
CCCindy Chiang
Cindy Chiang
LLLeo Liu
Leo Liu
ZSZuberwasim Sayyad
Zuberwasim Sayyad
SPShanti Pandey
Shanti Pandey
MGMichaela Gack
Michaela Gack

4 April 2025 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Open access
LSLucky Sarkar
Lucky Sarkar
LLLeo Liu
Leo Liu
DADhiraj Acharya
Dhiraj Acharya
JZJunji Zhu
Junji Zhu
ZSZuberwasim Sayyad
Zuberwasim Sayyad
MGMichaela Gack
Michaela Gack
The posttranslational modification (PTM) of innate immune sensor proteins by ubiquitin or ubiquitin-like proteins is crucial for regulating antiviral host responses. The cytoplasmic dsRNA receptor melanoma differentiation-associated protein 5 (MDA5) undergoes several PTMs including ISGylation within its first caspase activation and recruitment domain (CARD), which promotes MDA5 signaling. However, the relevance of MDA5 ISGylation for antiviral immunity in an infected organism has been elusive. Here, we generated knock-in mice (MDA5 K23R/K43R ) in which the two major ISGylation sites, K23 and K43, in MDA5, were mutated. Primary cells derived from MDA5 K23R/K43R mice exhibited abrogated endogenous MDA5 ISGylation and an impaired ability of MDA5 to form oligomeric assemblies, leading to blunted cytokine responses to MDA5 RNA-agonist stimulation or infection with encephalomyocarditis virus (EMCV) or West Nile virus. Phenocopying MDA5 −/− mice, the MDA5 K23R/K43R mice infected with EMCV displayed increased myocardial injury and mortality, elevated viral titers, and an ablated induction of cytokines and chemokines compared to WT mice. Molecular studies identified human HERC5 (and its functional murine homolog HERC6) as the primary E3 ligases responsible for MDA5 ISGylation and activation. Taken together, these findings establish the importance of CARD ISGylation for MDA5-mediated RNA virus restriction, promoting potential avenues for immunomodulatory drug design for antiviral or anti-inflammatory applications.

27 October 2020 in bioRxiv
Verified
Preprint
Open access
PDF file
LLLeo Liu
Leo Liu
JLJung-Hyun Lee
Jung-Hyun Lee
ZPZachary M. Parker
Zachary M. Parker
DADhiraj Acharya
Dhiraj Acharya
JCJessica J. Chiang
Jessica J. Chiang
MGMichaela Gack
Michaela Gack
Activation of the RIG-I-like receptors, RIG-I and MDA5, establishes an antiviral state by upregulating interferon (IFN)-stimulated genes (ISGs). Among these is ISG15 whose mechanistic roles in innate immunity still remain enigmatic. Here we report that ISGylation is essential for antiviral IFN responses mediated by the viral RNA sensor MDA5. ISG15 conjugation to the caspase activation and recruitment domains of MDA5 promotes the formation of higher-order assemblies of MDA5 and thereby triggers activation of innate immunity against a range of viruses including coronaviruses, flaviviruses and picornaviruses. The ISG15-dependent activation of MDA5 is antagonized through direct de-ISGylation mediated by the papain-like protease (PLpro) of SARS-CoV-2, a recently emerged coronavirus that causes the COVID-19 pandemic. Our work demonstrates a crucial role for ISG15 in the MDA5-mediated antiviral response, and also identifies a novel immune evasion mechanism of SARS-CoV-2, which may be targeted for the development of new antivirals and vaccines to combat COVID-19.

13 December 2021 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Closed access
PDF file
XLXing Liu
Xing Liu
DADhiraj Acharya
Dhiraj Acharya
EKEric Krawczyk
Eric Krawczyk
CKChase Kangas
Chase Kangas
MGMichaela U. Gack
Michaela U. Gack
BHBin He
Bin He
Significance: Herpes simplex viruses (HSV) can switch between lytic and latent infections, which are lifelong sources of recurrent diseases. In this process, the immediate early protein ICP0 crucially drives herpesvirus gene expression or reactivation from latency. The regulatory network of ICP0 expression is, however, largely obscure. We uncover that the HSV-1 virulence factor γ 1 34.5 interacts with and stabilizes ICP0. We also demonstrate that TRIM23, a cellular E3 ligase, triggers proteasomal degradation of ICP0 in the absence of γ 1 34.5. As such, removal of γ 1 34.5 or ICP0 from HSV-1 cripples viral growth, whereas ablation of TRIM23 restores viral production. These findings provide a framework of virus–host regulatory circuits, which may help in the rational design of antiviral or oncolytic therapeutics.